Treatment of geriatric depression

Depression and Anxiety

Volumn 8, Issue SUPPL. 1, 1998, Pages 32-42

  Small, Gary W ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Geriatric depression; Late life depression; Psychopharmacology; Treatment

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGING; ANXIETY NEUROSIS; ARTICLE; CARDIOTOXICITY; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HUMAN; INSOMNIA; NAUSEA; NERVOUSNESS; ORTHOSTATIC HYPOTENSION; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOTHERAPY; URINE RETENTION;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITION DISORDERS; DEPRESSIVE DISORDER; GERIATRIC PSYCHIATRY; HEALTH STATUS; HUMANS; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031786725     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:1+<32::AID-DA6>3.0.CO;2-J     Document Type: Article

References (123)

1. Alexopoulos GS, Lieberman KW, Young RC (1984) Platelet MAO activity and age at onset of depression in elderly depressed women. Am J Psychiatry 141:1276-1278.
2. Alexopoulos GS, Young RC, Meyers BS (1993a) Geriatric depression: Age of onset and dementia. Biol Psychiatry 34:141-145.
3. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T (1993b) The course of geriatric depression with "reversible dementia": A controlled study. Am J Psychiatry 150:1693-1699.
4. Anton SF, Revicki DA (1995) The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: A cost effectiveness study of nefazodone. Psychopharmacol Bull 31: 249-258.
5. APA (American Psychiatric Association) (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association.
6. Arya DK (1996) Lithium-induced neurotoxicity at serum lithium levels within the therapeutic range. Austral NZ J Psychiatry 30:871-873.
7. Bielski RJ, Friedel RO (1976) Prediction of tricyclic antidepressant response: A critical review. Arch Gen Psychiatry 33:1479-1489.
8. Blazer DG, Bachar JR, Manton KE (1986) Suicide in late life: Review and commentary. J Am Geriatr Soc 34:519-525.
9. Blazer D, Hughes DC, George LK (1987) The epidemiology of depression in an elderly community population. Gerontologist 27:281-287.
10. Branconnier RJ, Cole JO (1981) Effects of acute administration of trazodone and amitriptyline on cognition, cardiovascular function and salivation in the normal agitated patient. J Clin Psychopharmacol 1:2-8.
11. Bressler R, Katz MD (1993) Drug therapy for geriatric depression. Drugs Aging 3:195-219.
12. Burns BJ, Larson DB, Goldstrom ID, Johnson WE, Taube CA, Miller NE, Mathis ES (1988) Mental disorder among nursing home patients: Preliminary findings from the national nursing home survey pretest. Int J Geriatr Psychiatry 3:27-35.
13. Castleden CM, Duffin HM, Gulati RS (1986) Double-blind study of imipramine and placebo for incontinence due to bladder instability. Age Ageing 15:299-303.
14. Chiarello RJ, Cole JO (1987) The use of psychostimulants in general psychiatry: A reconsideration. Arch Gen Psychiatry 44:286-295.
15. Conwell Y, Nelson JC, Kim KM, Mazure CM (1989) Depression in late life: Age of onset as marker of a subtype. J Affective Disorders 17:189-195.
16. Conwell Y, Rotenberg M, Caine ED (1990) Completed suicide at age 50 and over. J Am Geriatr Soc 38:640-644.
17. Conwell Y, Duberstein PR, Cox C, Herrmann JH, Forbes NT, Caine, ED (1996) Relationships of age and axis I diagnoses in victims of completed suicide: A psychological autopsy study. Am J Psychiatry 153:1001-1008.
18. Cummings J, Small GW (1991) Dealing with writer's block in an older man: Depression, Parkinson's disease, or both? Hosp Comm Psychiatry 42:19-24.
19. Danish University Antidepressant Group (1990) Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 18:289-299.
20. Danjou P, Hackett D (1995) Safety and tolerance profile of venlafaxine. Int Clin Psychopharmacol 10:15-20.
21. Depression Guideline Panel (1993) Depression in Primary Care: Volume 2. Treatment of Major Depression. Clinical Practice Guideline, Number 5. Rockville, MD. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy Research. AHCPR Publication No. 93-0551, April.
22. Devanand DP, Nobler MS, Singer T, Kiersky JE, Turret N, Roose SP, Sackeim, HA (1994) Is dysthymia a different disorder in the elderly? Am J Psychiatry 151:1592-1599.
23. Diehl DJ, Houck PR, Paradis C, Miller M, Reynolds CF 3d (1993) Pretreatment systolic orthostatic blood pressure and treatment response in geriatric depression: A revisit. J Clin Psychopharm 13:189-193.
24. Dorman T (1992) Sleep and paroxetine: A comparison with mianserm in elderly depressed patients. Int J Clin Psychopharmacol 4:53-58.
25. Druckenbrod R, Mulsant BH (1994) Fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion: A geriatric case report and a review of the literature. J Geriatr Psychiatry Neurol 7:255-258.
26. Eaton WW, Holzer CE, Von Korff M, Anthony JC, Heizer JE, George L, Burnam A, Boyd JH, Kessler LG, Lucke BZ (1984) The design of the epidemiologic catchment area surveys: The control and measurement of error. Arch Gen Psychiatry 41:942-948.
27. Fawcett J, Marcus RN, Anton SF, O'brien K, Schwiderski U (1995) Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 56:27-42.
28. Feighner JP (1995) Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 56:574-579.
29. Feighner JP, Boyer WF, Meredith CH, Hendrickson (1988) An overview of fluoxetine in geriatric depression. Br J Psychiatry 153:105-108.
30. Finley PR (1994) Selective serotonin reuptake inhibitors: Pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 28:1359-1369.
31. Flint AJ, Rifat SL (1994) A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 14:353-356.
32. Freeman AM, Fleece L, Folks DG, Sokol RS, Hall KR, Pacifico AD, McGiffin DC, Kirklin JK, Zorn, GL, Karp RB (1986) Alprazolam treatment of postcoronary bypass anxiety and depression. J Clin Psychopharmacol 6:39-41.
33. Georgotas A, McCue RE, Cooper T, Chang I, Mir P, Welkowitz J (1987) Clinical predictors of response to antidepressants in elderly patients. Biol Psychiatry 22:733-740.
34. Georgotas A, McCue RE, Cooper TB, Nagachandran N, Chang I (1988) How effective and safe is continuation therapy in elderly depressed patients? Arch Gen Psychiatry 45:929-932.
35. Gerson SC, Plotkin DA, Jarvik LF (1988) Antidepressant drug studies, 1964 to 1986. Empirical evidence for aging patients. J Clin Psychopharmacol 8:311-322.
36. Goldstein L, Barker M, Segall F et al. (1996) Seizure and transient SIADH associated with sertraline. Am J Psychiatry 153:732.
37. Greenbaum DS, Mayle JE, Vanegeren LE, Jerome JA, Mayor JW, Greenbaum RB, Matson RW, Stein GE, Dean HA, Halvorsen NA (1987) Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci 32:257-266.
38. Greenblatt DJ, Friedman H, Burstein ES, Scavone JM, Blyden GT, Ochs HR, Miller LG, Harmatz JS, Shader RI (1987) Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacol Ther 42:193-200.
39. Guelfi JD, White C, Hackett D, Guichoux JY, Mgni G (1995) Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J Clin Psychiatry 56:450-458.
40. Hardy BG, Shulman KI, Zucchero C (1997) Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression. J Clin Psychopharm 17:22-26.
41. Haria M, Fitton A, McTavish D (1994) Trazodone: A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 4:331-335.
42. Hart RP, Colenda CC, Hamer RM (1991) Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry 148:73-77.
43. Herrmann N, Bremner KE, Naranjo CA (1997) Pharmacotherapy of late life mood disorders. Clin Neurosci 4:41-47.
44. Himmelhoch JM, Neil JF, May SJ, Fuchs CZ, Licata SM (1980) Age, dementia, dyskinesias, and lithium response. Am J Psychiatry 137:941-945.
45. Hindmarch I, Shillingford J, Shillingford C (1990) The effects of sertraline on psychomotor performance in elderly volunteers. J Clin Psychiatry 51:34-36.
46. Holroyd S, Smith D (1995) Disabling parkinsonism due to lithium: A case report. J Geriatr Psychiatry Neurol 8:118-119.
47. Jacoby RJ, Levy R (1980) Computed tomography in the elderly: Affective disorder. Br J Psychiatry 136:270-275.
48. Jarvik LF, Read SL, Mintz J, Neshkes RE (1983) Pretreatment orthostatic hypotension in geriatric depression: Predictor of response to imipramine and doxepin. J Clin Psychopharmacol 3:368-372.
49. Jenike MA (1985) MAO inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease). Am J Psychiatry 142:763-764.
50. Jonsson B, Bebbington PE (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 164:665-673.
51. Katon W, Raskind M (1980) Treatment of depression in the medically ill elderly with methylphenidate. Am J Psychiatry 137:963-965.
52. Katz IR, Lesher M, Kleban M, Jethanandani V, Parmelee P (1989) Clinical features of depression in the nursing home. Int Psychogeriatr 1:5-15.
53. Katz IR, Simpson GM, Curlik SM, Parmelee PA, Muhly C (1990) Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 51:41-47.
54. Kermis MD (1986) The epidemiology of mental disorder in the elderly: A response to the Senate/AARP report. Gerontologist 26:482-487.
55. Khan A, Rudolph R, Baumel B, Ferguson J, Ryan P, Shrivastava R (1995) Venlafaxine in depressed geriatric outpatients: An open-label clinical study. Psychopharm Bull 31:753-758.
56. Klawansky S (1994) Metaanalysis on the treatment of depression in late-life. In Schneider LS, Reynolds CF, Lebowitz B, Friedhoff A (eds): Diagnosis and Treatment of Depression in the Elderly: Proceedings of the NIH Consensus Development Conference. Washington DC: American Psychiatric Press.
57. Knegtermg H, Eijck M, Huijsman A (1994) Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging 5:192-199.
58. Koenig HG, Blazer DG (1992) Epidemiology of geriatric affective disorders. Clin Geriatr Med 8:235-251.
59. Lakshmanan M, Mion LC, Frengley JD (1986) Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients: A double-blind study. J Am Geratr Soc 34:421-426.
60. Lazarus LW, Moberg PJ, Langsley PR, Lingam VR (1994) Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison. Arch Physical Med Rehab 75:403-406.
61. Leinonen E, Koponen H, Leopola U (1993) Delirium during fluoxetine treatment: A case report. Ann Clin Psychiatry 5:255-257.
62. Leo RJ, Lichter DG, Hershey LA (1995) Parkinsonism associated with fluoxetine and cimetidine: A case report. J Geriatr Psychiatry Neurol 8:231-233.
63. Lewinsohn PM, Fenn DS, Stanton AK, Franklin J (1986) Relation of age at onset to duration of episode in unipolar depression. J Psychol Aging 1:63-68.
64. Lieberman E, Stoudemire A (1987) Use of tricyclic antidepressants in patients with glaucoma. Psychosomatics 28:145-148.
65. Lipsey JR, Robinson RG, Pearlson JD (1984) Nortriptyline treatment of post-stroke depression. A double-blind study. Lancet i:297-300.
66. Louie AK, Meltzer HY (1984) Lithium potentiation of antidepressant treatment. J Clin Psychopharmacol 4:316-321.
67. Marcopulos BA, Graves RE (1990) Antidepressant effect on memory in depressed older persons. J Clin Exp Neuropsychol 12:655-663.
68. McFarland BH (1994) Cost-effectiveness considerations for managed care systems: Treating depression in primary care. Am J Med 97:47S-58S.
69. Meyer UA, Zanger UM, Grant D, Blum M (1990) Genetic polymorphisms of drug metabolism. Adv Drug Res 19:197-241.
70. Montamat SC, Cusack BJ, Vestal RE (1989) Management of drug therapy in the elderly. N Engl J Med 321:303-309.
71. Murphy E, Smith R, Lindesay J, Slattery J (1988) Increased mortality rates in late-life depression. Br J Psychiatry 152:347-353.
72. Muth EA, Moyer JA, Haskins JT, Andree TH, Husbands GEM (1991) Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res 23:191-199.
73. Myers JK, Weissman MM, Tischler GL, Holzer CE III, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr, Kramer M (1984) Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 41:959-967.
74. Nemeroff CB, DeVane L, Pollock BG (1996) Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153:311-320.
75. Newhouse PA, Richter EM (1994) SSRIs in depressed elderly: A double-blind comparison of sertraline and fluoxetine in depressed geriatric outpatients. Presented at the meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 11-14.
76. NIH Consensus Conference (1992) Diagnosis and treatment of depression in late life. JAMA 268:1018-24.
77. Oxman TE (1996) Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 57:38-44.
78. Parker V, Paerg L, Maloney K, Rudolph R, Derivan A, Chiang S (1990) Effect of age and sex on the pharmacokinetics of venlafaxine. J Clin Pharmacol 30:832.
79. Paykel ES, Hollyman JA, Freeling P, Sedgwick P (1988) Predictors of therapeutic benefit from amitriptyline in mild depression: A general practice placebo-controlled trial. J Aff Disord 14:83-95.
80. Pearlson GD, Ross CA, Lohr WD, Rovner BW, Chase GA, Folstein MF (1990) Association between family history of affective disorder and the depressive syndrome of Alzheimer's disease. Am J Psychiatry 147:452-456.
81. Peselow ED, Sanfilipo MP, Difiglia C, Fieve RR (1992) Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 149:1324-1334.
82. Pollock BG (1994) Recent developments in drug metabolism of relevance to psychiatrists. Harvard Rev Psychiatry 2:204-213.
83. Preskorn S, Lane R, Magnus R (1996) The SSRI withdrawal syndrome. Eur Neuropsychopharm 6:121.
84. Prystowsky, EN (1996) Proarrhythmia during drug treatment of supraventricular tachycardia: Paradoxical risk of sinus rhythm for sudden death. Am J Cardiology 78:35-41.
85. Rapp SR, Davis KM (1989) Geriatric depression: Physicians' knowledge, perceptions, and diagnostic practices. Gerontologist 29:252-257.
86. Rapp SR, Parisi SA, Wallace CE (1991) Comorbid psychiatric disorders in elderly medical patients: A 1-year prospective study. J Am Geriatr Soc 39:124-131.
87. Rausch JL, Pavlinac DM, Newman PE (1984) Complete heart block following a single dose of trazodone. Am J Psychiatry 151:1472-1473.
88. Ravaris CL, Robinson DS, Ives JO, Nies A, Bartlett D (1980) Phenelzine and amitriptyline in the treatment of depression. Arch Gen Psychiatry 37:1075-1080.
89. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316:363-369.
90. Regier DA, Boyd JH, Burke JD, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ (1988) One-month prevalence of mental disorders in the United States: Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 45:977-986.
91. Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P (1989) Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 146:45-49.
92. Reynolds CF III (1994) Treatment of depression in late life. Am J Med 97:39S-46S.
93. Reynolds CF III, Frank E, Perel JM, Imber SD, Cornes C, Morycz RK, Mazumdar S, Miller MD, Pollock BG, Rifai AH (1992) Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: A preliminary report. Am J Psychiatry 149:1687-1692.
94. Reynolds CF III, Frank E, Perel JM, Mazumdar S, Kupfer DJ (1995) Maintenance therapies for late-life recurrent major depression: Research and review circa 1995. Int Psychogeriatr 7:27-39.
95. Roose SP, Glassman AH (1989) Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. J Clin Psychiatry Monograph 7:1-18.
96. Roose SP, Glassman AH, Attia E, Woodring S (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151:1735-1739.
97. Rudorfer MV, Potter WZ (1989) Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the "newer" versus the "older" drugs. Drugs 37:713-738.
98. Salzman C (1993) Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 54:23-28.
99. Schneider LS, Olin JT (1995) Efficacy of acute treatment for geriatric depression. Int Psychogeriatr 7:7-26.
100. Schneider LS, Sobin PB (1992) Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia. Psychopharmacol Bull 28:71-79.
101. Schneider LS, Sloane RB, Staples FR, Bender M (1986) Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psychopharmacol 6:172-176.
102. Schulz R, O'Brien AT, Bookwala J, Fleissner K (1995) Psychiatric and physical morbidity effects of dementia caregiving: Prevalence, correlates, and causes. Gerontologist 35:771-791.
103. Small GW (1989) Behavioral disorders in Alzheimer disease: Depression is common. Bull Clin Neurosci 54:2-7.
104. Small GW (1997) Recognizing and treating anxiety in the elderly. J Clin Psychiatry 58:41-47.
105. Small GW, Fawzy FI (1988) Psychiatric consultation for the medically ill elderly in the general hospital. Psychosomatics 29:94-103.
106. Small GW, Hamilton SL, Bystritsky A, Meyers BS, Ncmeroff CB, and the Fluoxetine Collaborative Study Group (1995) Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Int Psychogenatr 7:41-53.
107. Small GW, Schneider LS, Hamilton SL, Bystritsky A, Meyers BS, Nemeroff CB, and the Fluoxetine Collaborative Study Group (1996a) Site variability in a multisite geriatric depression trial. Int J Geriatr Psychiatry 11:1089-1095.
108. Small GW, Birkett M, Meyers BS, Koran LM, Bystritsky A, Nemeroff CB, and the Fluoxetine Collaborative Study Group (1996b) Impact of medical burden on quality of life and antidepressant response in geriatric major depression. J Am Geriatr Soc 44:1220-1225.
109. Spar JA, La Rue A (1985) Acute response to methylphenidate as a predictor of outcome of treatment with TCAs in the elderly. J Clin Psychiatry 46:466-469.
110. Spier SA, Frontera MA (1991) Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry 52:377-382.
111. Stack JA, Reynolds CF, Perel JM, Houck PR, Hoch CC, Kupfer DJ (1988) Pretreatment systolic orthostatic blood pressure (PSOP) and treatment response in elderly depressed inparients. J Clin Psychopharm 8:116-120.
112. Stoudemire A, Knos G, Gladson M, Markwalter H, Sung YF, Morris R, Cooper R (1990) Labetalol in the control of cardiovascular responses to electroconsulsive therapy in high-risk depressed medical patients. J Clin Psychiatry 51:508-512.
113. Stoudemire A, Hill CD, Morris R, Dalton ST (1995) Improvement in depression-related cognitive dysfunction following ECT. J Neuropsych Clin Neurosci 7:31-34.
114. Szuba MP, Leuchter AF (1992) Falling backward in two elderly patients taking bupropion. J Clin Psychiatry 53:157-159.
115. Thompson LE, Gallagher D, Breckenridge S (1987) Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychology 55:385-390.
116. Tignol J, Stoker MJ, Dunbar GC (1992) Paroxetine in the treatment of melancholia and severe depression. Int Clin Psychopharmacot 7:91-94.
117. Tollefson GD, Greist JH, Jefferson JW, Heiligenstein JH, Sayler ME, Tollefson SL, Koback K (1994) Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: A comparative trial of fluoxetine versus imipramine. J Clin Psychopharmacol 14:385-391.
118. Tollefson GD, Bosomworth JC, Heiligenstein JH, Porvin JH, Holman S (1995) A double-blind placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 7:89-104.
119. Tomac TA, Rummans TA, Pileggi TS, Li H (1997) Safety and efficacy of electroconvulsive therapy in patients over age 85. Am J Geriatr Psychiatry 5:126-130.
120. Valvanne J, Juva K, Erkinjuntti T, Tilvis R (1996) Major depression in the elderly: A population study in Helsinki. Int Psychogeriatr 8:437-443.
121. van Laar MW, van Willigenburg APP, Volkerts ER (1995) Acute and subchronic effect of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 15:30-40.
122. van Marwijk HW, de Bock GH, Hermans J, Mulder JD, Springer MP (1996) Prevalence of depression and clues to focus diagnosis. A study among Dutch general practice patients 65+ years of age. Scand J Primary Health Care 14:142-147.
123. Wesnes KA, Simpson PM, Christmas L, Anand R, McClelland GR (1989) The effects of moclobemide on cognition. J Neural Transm 28:91-102.